Clinical trial
A Multicenter, Open-label, Parallel Controlled, Prospective Cohort Study Evaluating Immunonutrition on the Improvement of Postoperative Adjuvant Chemotherapy Related Adverse Reactions in Patients With Gastrointestinal Tumors
NCT06085365 is registered in ClinicalTrials.gov with China Medical University, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open-label, Parallel Controlled, Prospective Cohort Study Evaluating Immunonutrition on the Improvement of Postoperative Adjuvant Chemotherapy Related Adverse Reactions in Patients With Gastrointestinal Tumors
- Lead sponsor
- China Medical University, China
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- July 24, 2023
- Completion date
- December 31, 2024
- Enrollment
- 324 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal tumors, immunonutrition, postoperative adjuvant chemotherapy